(R)-tert-Butyl (2-oxoazepan-3-yl)carbamate, 95.0%, 500mg

O-Isobutylhydroxylamine Hydrochloride, 95.0%, 25g

(R)-3-Amino-4-(4-methoxyphenyl)butanoic acid, 97%, 1g

Récepteur à vide droit, 24/29, 24/29, 1 pièce

4-(Difluoromethyl)-3-fluorobenzoic acid, 98%, 100mg

(r)-2-Amino-2-(3,5-dimethylphenyl)ethan-1-ol, 98%, 1g

(5-Fluoro-2-(methylcarbamoyl)phenyl)boronic acid, 95.0%, 1g

4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN], 95.0%, 500mg

(3R,3aS,6aS)-5-(tert-Butoxycarbonyl)hexahydro-2H-furo[2,3-c]pyrrole-3-carboxylic acid, 95%, 1g

N,N-Bis[(diphenylphosphino)methyl]-3-(triethoxysilyl)propylamine>95.0%(N)5g

3-Methoxy-5-(trifluoromethyl)pyridin-2-amine, 95.0%, 100mg

N-(tert-Butyl)-1H-pyrrole-2-carboxamide, 95.0%, 1g

Sulfate d'aluminium et de potassium dodécahydraté, 99 % min., Ph.Eur., 5 kg, emballage plastique.